IL4 and diabetes mellitus: The nanofibrous heparin-modified gelatin microsphere can improve IL-4 stabilization and prolong IL-4 release to modulate macrophage polarization from M1 to M2 phenotype, promoting bone regeneration in diabetes mellitus [79].